Jun 23, 2026
14 MIN READ

What Dosage Do You Start Losing Weight on Wegovy?

Weight loss on semaglutide typically begins during the titration phase, with meaningful results appearing by week 4 to 8 at therapeutic doses. Your individual response depends on genetics, metabolism, and dosing schedule.

GLP-1 weight loss starts at $129/mo Provider-reviewed options. No membership fees.

See if you qualify →

Jun 23, 2026
14 MIN READ

what dosage do you start losing weight on wegovy? — PlexusDx GLP-1 education

Last reviewed: June 23, 2026

Last updated: June 23, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide works through a gradual titration schedule, starting at low doses and increasing every four weeks until reaching your therapeutic dose. Most patients report their first noticeable appetite suppression within the opening two weeks, though measurable weight loss typically emerges between weeks four and eight as doses climb higher.

Understanding Semaglutide Titration and Weight Loss Timeline

Semaglutide requires a multi-week dose escalation because your body needs time to adapt to the medication's appetite-suppressing effects. The standard titration begins at 0.25 mg and increases by 0.25 mg each week until reaching a therapeutic dose, usually between 1.0 mg and 2.4 mg weekly. This gradual approach minimizes nausea and gastrointestinal side effects while allowing your system to acclimate.

Clinical trials show that weight reduction accelerates as doses increase throughout the titration phase. At lower opening doses, patients experience mild appetite changes but minimal weight shift. By week four to eight, when cumulative doses reach 0.75 mg to 1.0 mg, metabolic changes deepen and weight loss becomes measurable on the scale. The Semaglutide trials demonstrated an average of 5% to 10% body weight reduction by the eighth week for patients in active-treatment arms.

Dose-Dependent Weight Loss Results in Semaglutide Trials

Higher semaglutide doses produce greater weight loss outcomes compared to lower maintenance doses. Patients stabilized on 1.0 mg weekly typically lose 10% to 15% of starting body weight over 16 weeks. Those reaching 2.4 mg weekly showed approximately 15% to 20% weight reduction in comparable timeframes. This dose-response relationship reflects semaglutide's mechanism: stronger GLP-1 receptor activation at higher doses creates more potent appetite suppression and metabolic shifts.

Your body composition and genetic factors influence how quickly you respond at each dose level. The Precision Peptide Genetic Test from PlexusDx analyzes your GLP1R and GIPR genetic variants to predict which pathway dominates your peptide response. Understanding your genetic predisposition helps explain why some patients lose weight rapidly at 0.5 mg while others need 1.5 mg or higher for similar results.

How Long Until Semaglutide Shows Weight Loss Results

Week one to two marks the onset of appetite suppression, though the scale may not shift immediately. Many patients report eating smaller portions and experiencing earlier fullness during the initial low-dose phase. Week three to four brings the first measurable weight changes for responders, typically 2% to 3% of body weight. By week eight to twelve, as you reach your therapeutic dose, the cumulative effect becomes undeniable with 5% to 10% total reduction.

Plateauing occasionally occurs after 16 to 20 weeks at a single dose, which is normal physiology. Your body adapts to the medication's effects, requiring either a dose increase or a brief medication pause to restore sensitivity. PlexusDx compounded semaglutide starts at $149 per month regardless of your dose level, meaning your price remains flat even as your healthcare provider adjusts your dose upward for continued progress.

Factors That Affect Your Individual Weight Loss Rate on Semaglutide

Genetic variation in peptide receptor sensitivity explains why identical doses produce different outcomes across patients. Your FTO rs9939609 and MC4R rs17782313 variants influence how your body regulates appetite and energy expenditure independent of semaglutide. A person with specific FTO alleles may experience rapid weight loss at 1.0 mg, while someone with different variants might require 2.0 mg for equivalent results. The Precision Peptide Genetic Test maps 14 metabolic pathways and 150+ genetic insights specific to your peptide biology.

Behavioral factors—dietary consistency, physical activity, sleep quality, and stress management—interact with semaglutide's pharmacology to determine real-world results. A patient eating in a 300-calorie deficit with regular exercise sees faster weight loss than someone in a 100-calorie deficit with sedentary habits, even on identical doses. Starting your semaglutide journey with a registered dietitian and establishing sustainable habits maximizes your medication's potential.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

When will I start losing weight after my first semaglutide injection?

Appetite suppression typically begins within 2 to 5 days of your first dose, though measurable weight loss usually appears between weeks 4 and 8 as your dose reaches therapeutic levels during titration. Some patients see scale movement sooner if they have significant initial water-weight reduction, but meaningful fat loss requires sustained dose escalation and calorie deficit.

Do you need a higher dose of semaglutide to lose weight?

Higher doses produce greater weight loss in clinical trials, but even lower doses suppress appetite and enable weight reduction if coupled with dietary adherence. Your optimal dose balances efficacy against side-effect tolerance—some patients lose significant weight at 1.0 mg, while others need 2.4 mg. PlexusDx pricing remains constant across all doses because the principle is consistent: your dose may need to increase, but your monthly cost won't.

Can I buy compounded semaglutide without insurance through PlexusDx?

Yes—PlexusDx serves all 50 states without requiring insurance, membership fees, or prior authorizations. Compounded semaglutide injections start at $149 per month from licensed 503A compounding pharmacies, and HSA/FSA funds cover eligible patients. You can add the Precision Peptide Genetic Test for $99 after your first month to personalize your dosing strategy.

Is compounded semaglutide as effective as brand-name Wegovy?

PlexusDx compounded semaglutide uses the identical active ingredient (semaglutide) as Wegovy, prepared in licensed 503A compounding pharmacies under pharmaceutical-grade standards. The medication mechanism and weight-loss outcomes are equivalent; cost and access differ substantially. Compounded versions bypass brand-name pricing and insurance barriers, making consistent dosing accessible to more patients.

How does the Precision Peptide Genetic Test help predict my semaglutide response?

The test analyzes your GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 variants to map your peptide-pathway predispositions across 14 metabolic networks. These genetic markers influence how strongly your GLP-1 and GIP receptors respond to semaglutide, helping your provider anticipate your likely dose requirement and metabolism rate. At $99 after your first treatment month, the test personalizes your path to results.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake →

~60 seconds · $0 charged until your provider approves